Source: Annual Congress 2003 - COPD: risk factors and course of disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. D. Eisner, P. P. Katz, E. H. Yelin, L. Trupin, P. D. Blanc (San Francisco, United States Of America). Measurement of COPD severity: development and validation of a survey-based instrument. Eur Respir J 2003; 22: Suppl. 45, 2237

Member's Comments

No comment yet.

Related content which might interest you: Measurement of COPD severity: further validation of a survey-based instrument Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 Detection and evaluation severity of COPD by ipag questionnaires: evaluation of ipag questionnaires in COPD in Japan Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009 Development and first validation of the COPD Assessment Test Source: Eur Respir J 2009; 34: 648 Year: 2009 Development and validation of a new comorbidity index for COPD Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 Challenges in classification of asthma severity from prescription data: a pilot study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 The development of an instrument to assess the needs of people with COPD: a Delphi study Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Development and pilot testing of a new 7-item cough severity patient reported outcome measure Source: Annual Congress 2008 - COPD epidemiology Year: 2008 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 Development of an automated questionnaire for the early detection of COPD exacerbations (AQCE) Source: Annual Congress 2011 - COPD exacerbation Year: 2011 External multicentric validation of a COPD detection questionnaire Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Derivation and validation of the subscales of the severe asthma questionnaire Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Validity of the Brief physical activity assessment tool for clinical use in COPD Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease Year: 2017 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Validity of an automated telephonic system to assess exacerbation rates in prospective clinical COPD studies Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011 Longitudinal assessment in COPD patients: multidimensional variability and outcomes Source: Eur Respir J 2014; 43: 745-753 Year: 2014 Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Linguistic validation of the Clinical COPD Questionnaire (CCQ) for use in international studies Source: Eur Respir J 2005; 26: Suppl. 49, 513s Year: 2005 External validation of a COPD diagnostic questionnaire Source: Eur Respir J 2008; 31: 298-303 Year: 2008 Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020 Year: 2021 Self-reported COPD: spirometric validation in a resource limited setting Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008